Cencora, Inc. (LON:0HF3)
London
· Delayed Price · Currency is GBP · Price in USD 294.87
+5.67 (1.96%)
At close: Jul 3, 2025
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2012 - 2019 |
US Human Health | 259.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Human Health Growth | 13.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Animal Health | 5.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Animal Health Growth | 5.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Healthcare Solutions | 5.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Healthcare Solutions Growth | 5.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -8.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 126.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Alliance Healthcare | 23.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Alliance Healthcare Growth | 2.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -8.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 126.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2012 - 2019 |
Other | -608.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -7.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Distribution Services Segment Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Distribution Services Segment Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Segment Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Other Segment Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -608.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -7.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Healthcare Solutions Operating Income | 2.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Healthcare Solutions Operating Income Growth | 13.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Healthcare Solutions Operating Income | 713.38M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Healthcare Solutions Operating Income Growth | -8.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|